Viewing Study NCT00798395


Ignite Creation Date: 2025-12-24 @ 1:33 PM
Ignite Modification Date: 2026-02-27 @ 10:37 AM
Study NCT ID: NCT00798395
Status: COMPLETED
Last Update Posted: 2015-10-14
First Post: 2008-11-25
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study to Assess the Effect of Single and Multiple Doses Org 50081 and a Single Dose of Zopiclone on Next-day Driving Ability and Psychomotor Performance in Healthy Volunteers. (P05794) (COMPLETED)
Sponsor: Merck Sharp & Dohme LLC
Organization:

Study Overview

Official Title: A Randomized Double-blind, Placebo-controlled, 4-period Cross-over Study to Assess the Effect of Single and Multiple Doses of 1.5 mg and 4.5 mg Org 50081 and a Single Dose of 7.5 mg Zopiclone on Next-day Driving Ability and Psychomotor Performance in Healthy Volunteers.
Status: COMPLETED
Status Verified Date: 2015-10
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: This trial is to investigate the effect on next-day driving performance and psychomotor performance in healthy volunteers.
Detailed Description: None

Study Oversight

Has Oversight DMC: False
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?:

Secondary ID Infos

Secondary ID Type Domain Link View
21105 None None View